DIAMEDICA THERAPEUTICS INC. (DMAC) Operating income 2017–2025
DIAMEDICA THERAPEUTICS INC. (DMAC) annual operating income history from SEC filings — each fiscal year as reported.
-$34.4MFY2025 · since FY2017: -$4.5M → -$34.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$34.4M | -28.9% |
| FY2024 | -$26.7M | -25.5% |
| FY2023 | -$21.3M | -51.9% |
| FY2022 | -$14.0M | -2.6% |
| FY2021 | -$13.6M | -7.5% |
| FY2020 | -$12.7M | -9.5% |
| FY2019 | -$11.6M | -71.5% |
| FY2018 | -$6.8M | -49.6% |
| FY2017 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice